JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (5): 75-80.doi: 10.6040/j.issn.1671-7554.0.2015.107

Previous Articles     Next Articles

Effects of ethyl pyruvate in the treatment of hyperkinetic pulmonary hypertension

TANG Mengmeng1, JIN Nüwa2, LIU Chuanzhen1, LIU Kai1, CAO Guangqing1, WANG He1, PANG Xinyan1, WU Shuming1   

  1. 1. Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Department of Neurosurgery, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, Liaoning, China
  • Received:2015-01-28 Revised:2015-04-14 Online:2015-05-10 Published:2015-05-10

PDF (PC)

146

Abstract: Objective To evaluate the effects of ethyl pyruvate (EP) on hyperkinetic pulmonary arterial hypertension (PAH). Methods Rat hyperkinetic PAH models were established by shunting common carotid artery and internal jugular vein. After that, 30 rat models were randomly divided into 3 groups, with 10 rats in each group: EP treatment group, control group, and shunt group. Another 10 rats were enrolled in the sham-operation group as negative controls. Rats in the EP treatment group were given intraperitoneal injection of EP [50 mg/(kg·d)] for 30 days, and rats in the control group were injected with the same volume of normal saline. The systolic pulmonary arterial pressure (SPAP) was measured after that and then the right ventricular hypertrophy index (RVHI) was calculated after the heart was removed. The percentage of diameter thickness (WT%) and wall area (WA%) were calculated in lung tissues stained with HE. The levels of TNF-α and IL-6 in the serum were measured with ELISA and expression of NF-κB p65 in lung tissues was detected with Western blotting. Results Compared with shunt group, EP treatment group had significantly decreased SPAP, RVHI, WT%, WA%, the levels of TNF-α and IL-6 in serum, and expression of NF-κB p65 in lung tissues. Conclusion EP could ameliorate PAH and inhibit the remodeling of pulmonary blood vessels in hyperkinetic PAH rats by reducing the expression of NF-κB p65, synthesis and release of cytokines (TNF-α, IL- 6, etc.) and alleviate inflammation reaction.

Key words: Nuclear factor-κB p65, Ethyl pyruvate, Pulmonary arterial hypertension, Tumor necrosis factor alpha, Interleukin-6

CLC Number: 

  • R574
[1] 李强强, 顾虹, 罗毅. 先天性心脏病合并肺动脉高压的药物治疗进展[J]. 心肺血管病杂志, 2009, (3): 212-214. LI Qiangqiang, GU Hong, LUO Yi. Treatment progress of drugs for pulmonary hypertension with congenital heart disease[J]. Journal of Cardio Vascular Disease, 2009, (3): 212-214.
[2] 黄智伟, 吴炳祥. 肺动脉高压联合药物治疗的研究进展[J]. 心血管病学进展, 2009, 30(1): 109-111. HUANG Zhiwei, WU Bingxiang. The progress of pulmonary hypertension with combinated medication treatment[J]. Adv Cardiovasc Dis, 2009, 30(1): 109-111.
[3] Steinhorn RH, Fineman JR. The pathophysiology of pulmonary hypertension in congenital heart disease[J]. Artif Organs, 1999, 23(11): 970-974.
[4] 杨恒, 吕和平, 周蒙滔, 等. 丙酮酸乙酯对大鼠重症急性胰腺炎肾损伤的保护作用[J]. 肝胆胰外科杂志, 2011, 23(2): 89-91. YANG Heng, LV Heping, ZHOU Mengtao, et al. The protection of EP for kidney injury with severe acute pancreatitis in rats[J]. Journal of Hepatopancreatobiliary Surgery, 2011, 23(2): 89-91.
[5] Uchiyama T, Delude RL, Fink MP. Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion[J]. Intensive Care Med, 2003, 29(11): 2050-2058.
[6] Liu C, Yan Z, Fang C, et al. Establishment and comparison of two reliable hyperkinetic pulmonary hypertension models in rabbits[J]. J Thorac Cardiovasc Surg, 2014, 148(5): 2353-2359.
[7] Liu K, Liu R, Cao G, et al. Adipose-derived stromal cell autologous transplantation ameliorates pulmonary arterial hypertension induced by shunt flow in rat models[J]. Stem Cells Dev, 2010, 20(6): 1001-1010.
[8] 刘凯. 脂肪间充质干细胞移植治疗高动力性肺动脉高压的实验研究[D]. 山东大学, 2011.
[9] Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry[J]. Int J Cardiol, 2007, 120(2): 198-204.
[10] D'alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry[J]. Ann Intern Med, 1991, 115(5): 343-349.
[11] Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death[J]. Eur Heart J, 1998, 19(12): 1845-1855.
[12] Luan ZG, Zhang J, Yin XH, et al. Ethyl pyruvate significantly inhibits tumour necrosis factor-α, interleukin-1β and high mobility group box 1 releasing and attenuates sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury[J]. Clin Exp Immunol, 2013, 172(3): 417-426.
[13] Wang Y, Jing L, Zhao XM, et al. Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model[J]. Respir Res, 2011, 12(6): 26.
[14] 刘传振. hHIF-1α基因转染内皮祖细胞移植治疗高动力性肺动脉高压的实验研究[D]. 山东大学, 2014. LIU Chuanzhen. Combined human HIF-la and homogeneous endothelial progenitor cells therapy attenuates hyperkinetic pulmonary arterial hypertension in rabbits[D]. Shandong University, 2014.
[15] Taylor MD, Grand TJ, Cohen JE, et al. Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypass[J]. Heart Lung Circ, 2005, 14(1): 25-31.
[16] Yang R, Gallo DJ, Baust JJ, et al. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock[J]. Am J Physiol Gastrointest Liver Physiol, 2002, 283(1): 212-221.
[17] Fink MP. Ethyl pyruvate[J]. Curr Opin Anaesthesiol, 2008, 21(2): 160-167.
[18] Van Zoelen MA, Bakhtiari K, Dessing MC, et al. Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells[J]. Thromb Haemost, 2006, 96(6): 789.
[19] Hessel MH, Steendijk P, Den Adel B, et al. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat[J]. Am J Physiol Heart Circ Physiol, 2006, 291(5): 2424-2430.
[20] Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension[J]. N Engl J Med, 2004, 351(14): 1425-1436.
[21] Martin KB, Klinger JR, Rounds SI. Pulmonary arterial hypertension: new insights and new hope[J]. Respirology, 2006, 11(1): 6-17.
[22] Price LC, Wort SJ, Dorfmuller P, et al. Inflammation in pulmonary arterial hypertension[J]. Chest, 2012, 141(1): 210-221.
[23] Humbert M, Monti G, Fartoukh M, et al. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients[J]. Eur Respir J, 1998, 11(3): 554-559.
[24] Brock M, Trenkmann M, Gay RE, et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3–microRNA cluster 17/92 pathway[J]. Circ Res, 2009, 104(10): 1184-1191.
[25] Steiner MK, Syrkina OL, Kolliputi N, et al. Interleukin-6 overexpression induces pulmonary hypertension[J]. Circ Res, 2009, 104(2): 236-244.
[26] Marsh CB, Wewers MD. The pathogenesis of sepsis: factors that modulate the response to gram-negative bacterial infection[J]. Clin Chest Med, 1996, 17(2): 183-197.
[27] Dunican AL, Leuenroth SJ, Grutkoski P, et al. TNF alpha-induced suppression of PMN apoptosis is mediated through interleukin-8 production[J]. Shock, 2000, 14(3): 284-289.
[28] Blackwell TS, Christman JW. The role of nuclear factor-κ B in cytokine gene regulation[J]. Am J Respir Cell Mol Biol, 1997, 17(1): 3-9.
[1] ZHANG Luan, CHEN Ou, LUAN Yun, ZHU Xiaobo, CHEN Yuan, WANG Yibiao. Effects of gemigliptin on the therapeutic effect and inflammatory factors of monocrotaline-induced pulmonary arterial hypertension in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 19-22.
[2] LIU Huimin, LIU Deng, LI Xiaoyu, ZOU Shufeng, JIANG Limin, LI Yuhuan. Effect of Lobelia alkaloids on endothelin-1 signal pathway in a rat model of pulmonary arterial hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(8): 1-4.
[3] WANG Weiyan, YANG Qingrui, YUAN Yuan, YANG Xinglin, ZHANG Yuanchao. Meta-analysis of TNFAIP3 gene polymorphism with rheumatoid arthritis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 75-80.
[4] HAN Wenjie1, YU Suguo1, CUI Xiangyu2. Effects of N-acetylcysteine on GLP-1 and IL-6 in high-fat-diet rats with insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 12-16.
[5] QIU Huihui1， YE Liping1， WEN Youfeng2， LI Dan1， SONG Jia1. Effects of IL-6 on the expressions of bcl-2，cyclinD1 and VEGF in ovarian cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 17-21.
[6] ZHANG Qingwei1, WANG Chunting2, Wang Qizhi2, ZHANG Lin2, WANG Peng2, MENG Mei2. Protective effect and mechanism of ethyl pyruvate on the small intestine barrier in rats with sepsis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 30-34.
[7] WANG Ya-yun1, WANG Yi-biao1, ZHANG Xue1, LIN Mei1, SU Hong1, MA Yu1, ZHU Xiao-bo1, CHEN Ou2. Effect of PS-341 on expression of Nrf2/NF-κB in rats with pulmonary arterial hypertension and its mechanism [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 6-11.
[8] GAO Shu-chun, GENG Da-ying, CUI Lei, ZHANG Li-xin, ZHANG Qin-gang， CHEN Shi-jun. Influence  of  Telbivudine  on  serum IL-2  and IL-6 in chronic hepatitis B [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 92-95.
[9] ZHOU Hong-xia1, LOU Ning2, WEI Zi-feng1, ZHANG Yu-xin1, MENG Ling-li1, ZHANG Zuo-feng1. Expressions of NF-κB and IL-6 around the hematoma and their correlations
with cerebral edema after intracerebral hemorrhage in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(11): 30-33.
[10] YAO Li1， SUN Qin-feng2, YANG Chun-hui1. Detection of serum TNF-α、IL-6 and CRP level in patients
with preeclampsia and periodontal disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 123-126.
[11] WANG Shu-jun， GENG Qin， ZHANG Xiu-ying, ZHANG Hong-ju, WEI Qiao-feng, CUI Yan-hui. Regulatory role of the let-7/miR-98 family in the IL-6 expression [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 62-65.
[12] GULIBAHAER·Abulimiti1, GONG Xiao-jin1, GULINAER·Kuerban2. Expressions of MMP-9 and IL-6 in pancreatic neoplasm and  their relationships with clinical pathological classification [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(9): 99-.
[13] ZHANG Zhaohua1, WANG Yibiao1, LUAN Yun2, SU Hong1, MA Yu1, LIN Mei1, SUN Ruopeng3 . Effect of mesenchymal stem cells implantation on experimental  impairment caused by pulmonary arterial hypertension in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 31-.
[14] JIAO Qi1,2, WANG Wei3, FAN Quanxin4. Effect of different balanced ultrafiltration volumes on inflammatory  mediators during cardiopulmonary bypass [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 136-.
[15] LIANG Xu-yang, CHENG Bao-quan, JIA Jun-ying, WANG Xu, REN Hong-bo. Inhibitory effect of ethyl pyruvate on the human  pancreatic carcinoma cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(5): 48-53.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd